SCHEMBL16769409

SCHEMBL16769409

CCCCCCc1cc(CCCCCC)cc(-c2nc(-c3ccc(C)c(C)c3)nc(-c3ccc(C)c(C)c3)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 8/20 0.44
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
PTGS2 P35354 2/20 0.40
RARA P10276 1/20 0.40
MTOR P42345 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
HSD11B1 P28845 1/20 0.38
CTSK P43235 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16769386 0.90 ALDH1A1 (0.52) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL16769374 0.90 ALDH1A1 (0.52) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL16769383 0.88 RARB (0.53) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL15281189 0.85 RARB (0.57) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL16769378 0.85 RARB (0.48) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL15281180 0.85 RAB9A (0.47) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL15281181 0.84 MEN1 (0.46) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL19559603 0.83 RAB9A (0.39) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL16769422 0.83 MEN1 (0.43) RARBMAPTMEN1ALDH1A1KMT2A
SCHEMBL18216907 0.83 PTGS2 (0.46) RARBMAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9905767-B2 High-molecular compound and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-27 US disclosed
US-9853218-B2 High-molecular compound and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-12-26 US disclosed
US-20150207077-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-23 US disclosed
US-20150155495-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150155495-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME ARL1, CCNL2, CRKL RARB 658/4885MAPT 2720/4885MEN1 402/4885
US-20150207077-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME ARL1, GRK1, GNA11 RARB 609/4885MAPT 3221/4885MEN1 514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.